Rallybio clinical trials we track

Check company identity source

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Number of Participants with treatment related adverse events as defined by CTCAE 5.0 Measure: Maternal exposure to RLYB212 as measured in serum. After: Measure: Number of Participants With Treatment Related Adverse Events as Defined by CTCAE 5.0 Measure: Maternal Exposure to RLYB212 as Measured in Serum.

Check registry source

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 8 participants (planned). After: 1 participants (actual).

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source